Cytelligen, Inc. is a San Diego-based biotechnology company specializing in cutting-edge CTC (Circulating Tumor Cell) and CTEC (Circulating Tumor Endothelial Cell) technology.
With a focus on developing innovative products and publishing groundbreaking research, Cytelligen is at the forefront of advancing cancer diagnostics and treatment.
Generated from the website